世界の慢性骨髄性白血病（CML）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Chronic Myeloid Leukemia (CML) Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4014
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、109ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、慢性骨髄性白血病（CML）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（標的療法、化学療法、放射線療法、脾臓摘出術、幹細胞移植）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・慢性骨髄性白血病（CML）治療の市場動向
・企業の競争状況、市場シェア
・慢性骨髄性白血病（CML）治療の種類別市場規模と予測2016-2027（標的療法、化学療法、放射線療法、脾臓摘出術、幹細胞移植）
・慢性骨髄性白血病（CML）治療の用途別市場規模と予測2016-2027（病院、診療所、その他）
・慢性骨髄性白血病（CML）治療の北米市場規模2016-2027（アメリカ、カナダ）
・慢性骨髄性白血病（CML）治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・慢性骨髄性白血病（CML）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・慢性骨髄性白血病（CML）治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・慢性骨髄性白血病（CML）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Novartis AG、Bristol-Myers Squibb、Teva Pharmaceuticals Industries Ltd.、ARIAD Pharmaceuticals, Inc.、Pfizer, Inc.、Hospira, Inc.、Prism Pharmaceuticals、Incyte Corporation、Bio-Path Holdings、Stragen Pharma SA、Otsuka Pharmaceutical Co., Ltd.）
・結論

Chronic myeloid leukaemia (CML) is a type cancer that affects the blood and bone marrow.

Market Analysis and Insights: Global Chronic Myeloid Leukemia (CML) Treatment Market
The global Chronic Myeloid Leukemia (CML) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chronic Myeloid Leukemia (CML) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chronic Myeloid Leukemia (CML) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chronic Myeloid Leukemia (CML) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chronic Myeloid Leukemia (CML) Treatment market.

Global Chronic Myeloid Leukemia (CML) Treatment Scope and Market Size
Chronic Myeloid Leukemia (CML) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Myeloid Leukemia (CML) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Targeted Therapy
Chemotherapy
Radiation Therapy
Splenectomy
Stem Cell Transplant

Segment by Application
Hospitals
Clinic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis AG
Bristol-Myers Squibb
Teva Pharmaceuticals Industries Ltd.
ARIAD Pharmaceuticals, Inc.
Pfizer, Inc.
Hospira, Inc.
Prism Pharmaceuticals
Incyte Corporation
Bio-Path Holdings
Stragen Pharma SA
Otsuka Pharmaceutical Co., Ltd.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Targeted Therapy
1.2.3 Chemotherapy
1.2.4 Radiation Therapy
1.2.5 Splenectomy
1.2.6 Stem Cell Transplant
1.3 Market by Application
1.3.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Perspective (2016-2027)
2.2 Chronic Myeloid Leukemia (CML) Treatment Growth Trends by Regions
2.2.1 Chronic Myeloid Leukemia (CML) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chronic Myeloid Leukemia (CML) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Chronic Myeloid Leukemia (CML) Treatment Industry Dynamic
2.3.1 Chronic Myeloid Leukemia (CML) Treatment Market Trends
2.3.2 Chronic Myeloid Leukemia (CML) Treatment Market Drivers
2.3.3 Chronic Myeloid Leukemia (CML) Treatment Market Challenges
2.3.4 Chronic Myeloid Leukemia (CML) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Chronic Myeloid Leukemia (CML) Treatment Players by Revenue
3.1.1 Global Top Chronic Myeloid Leukemia (CML) Treatment Players by Revenue (2016-2021)
3.1.2 Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chronic Myeloid Leukemia (CML) Treatment Revenue
3.4 Global Chronic Myeloid Leukemia (CML) Treatment Market Concentration Ratio
3.4.1 Global Chronic Myeloid Leukemia (CML) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Myeloid Leukemia (CML) Treatment Revenue in 2020
3.5 Chronic Myeloid Leukemia (CML) Treatment Key Players Head office and Area Served
3.6 Key Players Chronic Myeloid Leukemia (CML) Treatment Product Solution and Service
3.7 Date of Enter into Chronic Myeloid Leukemia (CML) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Myeloid Leukemia (CML) Treatment Breakdown Data by Type
4.1 Global Chronic Myeloid Leukemia (CML) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Type (2022-2027)

5 Chronic Myeloid Leukemia (CML) Treatment Breakdown Data by Application
5.1 Global Chronic Myeloid Leukemia (CML) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Chronic Myeloid Leukemia (CML) Treatment Market Size (2016-2027)
6.2 North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type
6.2.1 North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2016-2021)
6.2.2 North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2022-2027)
6.2.3 North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2016-2027)
6.3 North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application
6.3.1 North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2016-2021)
6.3.2 North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2022-2027)
6.3.3 North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2016-2027)
6.4 North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Country
6.4.1 North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2016-2021)
6.4.2 North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size (2016-2027)
7.2 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Type
7.2.1 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2016-2027)
7.3 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Application
7.3.1 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2016-2027)
7.4 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Country
7.4.1 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Type
8.2.1 Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Application
8.3.1 Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Region
8.4.1 Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size (2016-2027)
9.2 Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type
9.2.1 Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2016-2027)
9.3 Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application
9.3.1 Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2016-2027)
9.4 Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Country
9.4.1 Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Type
10.2.1 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Application
10.3.1 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Country
10.4.1 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Chronic Myeloid Leukemia (CML) Treatment Introduction
11.1.4 Novartis AG Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
11.1.5 Novartis AG Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Introduction
11.2.4 Bristol-Myers Squibb Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Teva Pharmaceuticals Industries Ltd.
11.3.1 Teva Pharmaceuticals Industries Ltd. Company Details
11.3.2 Teva Pharmaceuticals Industries Ltd. Business Overview
11.3.3 Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Introduction
11.3.4 Teva Pharmaceuticals Industries Ltd. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
11.3.5 Teva Pharmaceuticals Industries Ltd. Recent Development
11.4 ARIAD Pharmaceuticals, Inc.
11.4.1 ARIAD Pharmaceuticals, Inc. Company Details
11.4.2 ARIAD Pharmaceuticals, Inc. Business Overview
11.4.3 ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Introduction
11.4.4 ARIAD Pharmaceuticals, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
11.4.5 ARIAD Pharmaceuticals, Inc. Recent Development
11.5 Pfizer, Inc.
11.5.1 Pfizer, Inc. Company Details
11.5.2 Pfizer, Inc. Business Overview
11.5.3 Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Introduction
11.5.4 Pfizer, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
11.5.5 Pfizer, Inc. Recent Development
11.6 Hospira, Inc.
11.6.1 Hospira, Inc. Company Details
11.6.2 Hospira, Inc. Business Overview
11.6.3 Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Introduction
11.6.4 Hospira, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
11.6.5 Hospira, Inc. Recent Development
11.7 Prism Pharmaceuticals
11.7.1 Prism Pharmaceuticals Company Details
11.7.2 Prism Pharmaceuticals Business Overview
11.7.3 Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Introduction
11.7.4 Prism Pharmaceuticals Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
11.7.5 Prism Pharmaceuticals Recent Development
11.8 Incyte Corporation
11.8.1 Incyte Corporation Company Details
11.8.2 Incyte Corporation Business Overview
11.8.3 Incyte Corporation Chronic Myeloid Leukemia (CML) Treatment Introduction
11.8.4 Incyte Corporation Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
11.8.5 Incyte Corporation Recent Development
11.9 Bio-Path Holdings
11.9.1 Bio-Path Holdings Company Details
11.9.2 Bio-Path Holdings Business Overview
11.9.3 Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Introduction
11.9.4 Bio-Path Holdings Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
11.9.5 Bio-Path Holdings Recent Development
11.10 Stragen Pharma SA
11.10.1 Stragen Pharma SA Company Details
11.10.2 Stragen Pharma SA Business Overview
11.10.3 Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Introduction
11.10.4 Stragen Pharma SA Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
11.10.5 Stragen Pharma SA Recent Development
11.11 Otsuka Pharmaceutical Co., Ltd.
11.11.1 Otsuka Pharmaceutical Co., Ltd. Company Details
11.11.2 Otsuka Pharmaceutical Co., Ltd. Business Overview
11.11.3 Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Introduction
11.11.4 Otsuka Pharmaceutical Co., Ltd. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
11.11.5 Otsuka Pharmaceutical Co., Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Targeted Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Radiation Therapy
Table 5. Key Players of Splenectomy
Table 6. Key Players of Stem Cell Transplant
Table 7. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Regions (2016-2021)
Table 11. Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Regions (2022-2027)
Table 13. Chronic Myeloid Leukemia (CML) Treatment Market Trends
Table 14. Chronic Myeloid Leukemia (CML) Treatment Market Drivers
Table 15. Chronic Myeloid Leukemia (CML) Treatment Market Challenges
Table 16. Chronic Myeloid Leukemia (CML) Treatment Market Restraints
Table 17. Global Chronic Myeloid Leukemia (CML) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Players (2016-2021)
Table 19. Global Top Chronic Myeloid Leukemia (CML) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Myeloid Leukemia (CML) Treatment as of 2020)
Table 20. Ranking of Global Top Chronic Myeloid Leukemia (CML) Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Chronic Myeloid Leukemia (CML) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Chronic Myeloid Leukemia (CML) Treatment Product Solution and Service
Table 24. Date of Enter into Chronic Myeloid Leukemia (CML) Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Chronic Myeloid Leukemia (CML) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Chronic Myeloid Leukemia (CML) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Novartis AG Company Details
Table 65. Novartis AG Business Overview
Table 66. Novartis AG Chronic Myeloid Leukemia (CML) Treatment Product
Table 67. Novartis AG Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021) & (US$ Million)
Table 68. Novartis AG Recent Development
Table 69. Bristol-Myers Squibb Company Details
Table 70. Bristol-Myers Squibb Business Overview
Table 71. Bristol-Myers Squibb Chronic Myeloid Leukemia (CML) Treatment Product
Table 72. Bristol-Myers Squibb Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021) & (US$ Million)
Table 73. Bristol-Myers Squibb Recent Development
Table 74. Teva Pharmaceuticals Industries Ltd. Company Details
Table 75. Teva Pharmaceuticals Industries Ltd. Business Overview
Table 76. Teva Pharmaceuticals Industries Ltd. Chronic Myeloid Leukemia (CML) Treatment Product
Table 77. Teva Pharmaceuticals Industries Ltd. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021) & (US$ Million)
Table 78. Teva Pharmaceuticals Industries Ltd. Recent Development
Table 79. ARIAD Pharmaceuticals, Inc. Company Details
Table 80. ARIAD Pharmaceuticals, Inc. Business Overview
Table 81. ARIAD Pharmaceuticals, Inc. Chronic Myeloid Leukemia (CML) Treatment Product
Table 82. ARIAD Pharmaceuticals, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021) & (US$ Million)
Table 83. ARIAD Pharmaceuticals, Inc. Recent Development
Table 84. Pfizer, Inc. Company Details
Table 85. Pfizer, Inc. Business Overview
Table 86. Pfizer, Inc. Chronic Myeloid Leukemia (CML) Treatment Product
Table 87. Pfizer, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021) & (US$ Million)
Table 88. Pfizer, Inc. Recent Development
Table 89. Hospira, Inc. Company Details
Table 90. Hospira, Inc. Business Overview
Table 91. Hospira, Inc. Chronic Myeloid Leukemia (CML) Treatment Product
Table 92. Hospira, Inc. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021) & (US$ Million)
Table 93. Hospira, Inc. Recent Development
Table 94. Prism Pharmaceuticals Company Details
Table 95. Prism Pharmaceuticals Business Overview
Table 96. Prism Pharmaceuticals Chronic Myeloid Leukemia (CML) Treatment Product
Table 97. Prism Pharmaceuticals Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021) & (US$ Million)
Table 98. Prism Pharmaceuticals Recent Development
Table 99. Incyte Corporation Company Details
Table 100. Incyte Corporation Business Overview
Table 101. Incyte Corporation Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021) & (US$ Million)
Table 102. Incyte Corporation Recent Development
Table 103. Bio-Path Holdings Company Details
Table 104. Bio-Path Holdings Business Overview
Table 105. Bio-Path Holdings Chronic Myeloid Leukemia (CML) Treatment Product
Table 106. Bio-Path Holdings Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021) & (US$ Million)
Table 107. Bio-Path Holdings Recent Development
Table 108. Stragen Pharma SA Company Details
Table 109. Stragen Pharma SA Business Overview
Table 110. Stragen Pharma SA Chronic Myeloid Leukemia (CML) Treatment Product
Table 111. Stragen Pharma SA Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021) & (US$ Million)
Table 112. Stragen Pharma SA Recent Development
Table 113. Otsuka Pharmaceutical Co., Ltd. Company Details
Table 114. Otsuka Pharmaceutical Co., Ltd. Business Overview
Table 115. Otsuka Pharmaceutical Co., Ltd. Chronic Myeloid Leukemia (CML) Treatment Product
Table 116. Otsuka Pharmaceutical Co., Ltd. Revenue in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021) & (US$ Million)
Table 117. Otsuka Pharmaceutical Co., Ltd. Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Targeted Therapy Features
Figure 3. Chemotherapy Features
Figure 4. Radiation Therapy Features
Figure 5. Splenectomy Features
Figure 6. Stem Cell Transplant Features
Figure 7. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Chronic Myeloid Leukemia (CML) Treatment Report Years Considered
Figure 12. Global Chronic Myeloid Leukemia (CML) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Chronic Myeloid Leukemia (CML) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Regions (2022-2027)
Figure 16. Global Chronic Myeloid Leukemia (CML) Treatment Market Share by Players in 2020
Figure 17. Global Top Chronic Myeloid Leukemia (CML) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Myeloid Leukemia (CML) Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Chronic Myeloid Leukemia (CML) Treatment Revenue in 2020
Figure 19. Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Chronic Myeloid Leukemia (CML) Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2016-2027)
Figure 23. North America Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2016-2027)
Figure 24. North America Chronic Myeloid Leukemia (CML) Treatment Market Share by Country (2016-2027)
Figure 25. United States Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2016-2027)
Figure 29. Europe Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2016-2027)
Figure 30. Europe Chronic Myeloid Leukemia (CML) Treatment Market Share by Country (2016-2027)
Figure 31. Germany Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Chronic Myeloid Leukemia (CML) Treatment Market Share by Region (2016-2027)
Figure 41. China Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Chronic Myeloid Leukemia (CML) Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Chronic Myeloid Leukemia (CML) Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Chronic Myeloid Leukemia (CML) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Novartis AG Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
Figure 62. Teva Pharmaceuticals Industries Ltd. Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
Figure 63. ARIAD Pharmaceuticals, Inc. Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
Figure 64. Pfizer, Inc. Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
Figure 65. Hospira, Inc. Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
Figure 66. Prism Pharmaceuticals Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
Figure 67. Incyte Corporation Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
Figure 68. Bio-Path Holdings Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
Figure 69. Stragen Pharma SA Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
Figure 70. Otsuka Pharmaceutical Co., Ltd. Revenue Growth Rate in Chronic Myeloid Leukemia (CML) Treatment Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

以下、関連資料のご紹介

世界の慢性リンパ性白血病治療薬市場規模・現状・予測（2021年-2027年）

Global Chronic Lymphocytic Leukemia Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4012 2021年6月 120Pages
QYResearch社発行の本調査レポートでは、慢性リンパ性白血病治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、点滴薬、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界の結核（TB）治療市場規模・現状・予測（2021年-2027年）

Global Tuberculosis (TB) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4987 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、結核（TB）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イソニアジド、リファンピン（リファディン、リマクタン）、エタンブトール（ミアンブトール）、ピラジナミド）、用途別市場規模（活動性結核、潜...

世界のT細胞急性リンパ芽球性白血病治療市場規模・現状・予測（2021年-2027年）

Global T-cell Acute Lymphoblastic Leukemia Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4935 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、T細胞急性リンパ芽球性白血病治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、骨髄移植、標的療法、免疫療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、...

世界のB細胞非ホジキンリンパ腫（NHL）治療市場規模・現状・予測（2021年-2027年）

Global B-Cell Non-Hodgkin's Lymphoma (NHL) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3894 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、B細胞非ホジキンリンパ腫（NHL）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、その他）、用途別市場規模（病院、診療所、外来手術センター、その他）、主要地域別市場規模（北米...

世界の顧みられない熱帯病（NTD）治療市場規模・現状・予測（2021年-2027年）

Global Neglected Tropical Disease (NTD) Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4558 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、顧みられない熱帯病（NTD）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療薬、ワクチン）、用途別市場規模（病院・クリニック、診断センター、学術・研究機関）、主要地域別市場規模（北米、アメリカ...

世界の慢性歯肉口内炎治療市場規模・現状・予測（2021年-2027年）

Global Chronic Gingivostomatitis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5660 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、慢性歯肉口内炎治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬、抗ウイルス薬、抗菌薬、その他）、用途別市場規模（病院＆診療所、大学＆研究機関、その他）、主要地域別市場規模（北...

世界の非ホジキンリンパ腫＆慢性リンパ腫治療市場規模・現状・予測（2021年-2027年）

Global Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4588 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、非ホジキンリンパ腫＆慢性リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（B細胞、T細胞）、用途別市場規模（化学療法、免疫療法、標的療法、放射線療法、幹細胞移植）、主要地域別市場規模（北米、...

世界の脊髄性筋萎縮症（SMA）治療市場規模・現状・予測（2021年-2027年）

Global Spinal Muscular Atrophy (SMA) Therapeutic Market Size, Status and Forecast 2021-2027
QFJ1-5351 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、脊髄性筋萎縮症（SMA）治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヌシネルセン、オナセムノゲンアベパルボベック）、用途別市場規模（タイプ1SMA、タイプ2 SMA、その他）、主要地域別市場規...

世界の食物アレルギー診断＆治療市場規模・現状・予測（2021年-2027年）

Global Food Allergy Diagnostics and Therapeutics Market Size, Status and Forecast 2021-2027
QFJ1-4236 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、食物アレルギー診断＆治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（診断製品、機器、消耗品、サービス）、用途別市場規模（学術研究所、病院＆診療所、診断研究所）、主要地域別市場規模（北米、アメリカ、...

世界の家族性大腸腺腫症治療市場規模・現状・予測（2021年-2027年）

Global Familial Adenomatous Polyposis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5736 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、家族性大腸腺腫症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イコサペント、塩酸エフロルニチン、アスピリン、CEQ-508、その他）、用途別市場規模（診療所、病院、その他）、主要地域別市場規模（...

世界のT細胞急性リンパ芽球性白血病治療市場規模・現状・予測（2021年-2027年） T-cell acute lymphoblastic leukemia (T-ALL) is a type of acute lymphoblastic leukemia, with features similar to lymphoma. It affects white blood cells called T lymphocytes. Market Analysis and Insights: Global T-cell Acute Lymphoblastic Leukemia Treatment Market The global T-cell Acute Lymphoblastic…
世界の非ホジキンリンパ腫＆慢性リンパ腫治療市場規模・現状・予測（2021年-2027年） Non-Hodgkins Lymphoma also known as NHL is a heterogeneous and complex group of disorders that are characterized by clonal proliferation of lymphocytes at multiple stages of maturation. There are approximately 30 types of NHLs with varying pathological, clinical, and genetic features. Chronic Lympho…
世界の慢性リンパ性白血病治療薬市場規模・現状・予測（2021年-2027年） Chronic Lymphocytic Leukemia (CLL) is a type of hematological malignancy marked by excessive proliferation of abnormal white blood cells. CLL predominantly affects the B-cell lymphocytes which are involved in the production of antibodies to fight against infections and foreign antigens. Rising incid…
世界の慢性歯肉口内炎治療市場規模・現状・予測（2021年-2027年） Chronic gingivostomatitis is a common infection of mouth and gums, leading to drooling and swelling. Sometimes lesions in the mouth resembles the canker sores. This infection is common among children. Market Analysis and Insights: Global Chronic Gingivostomatitis Treatment Market The global Chronic …
世界の同種異系幹細胞治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Allogeneic Stem Cell Therapy Market The global Allogeneic Stem Cell Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integri…